Breaking News Instant updates and real-time market news.

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

19:30
09/23/18
09/23
19:30
09/23/18
19:30

Fly Intel: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Comcast (CMCSA; CMCSK) announced that it has prevailed with the highest offer price in the auction to acquire the entire issued and to be issued share capital of Sky (SKYAY) with an offer price of GBP17.28 per Sky share. This implies a value of $40B for the fully diluted share capital of Sky. The announcement ends the competitive bidding process for Sky. 21st Century Fox (FOXA) was the other bidder. 2. Regal Beloit (RBC) announced that Mark Gliebe, Chairman and CEO, will retire from the company after the completion of calendar year 2018. Regal's Board of Directors has begun a process to identify Gliebe's successor, who has agreed to lead the company until a successor has been named and to resign from the Board effective as of his retirement date as CEO. Additionally, the company confirmed 2018 adjusted diluted EPS guidance of $5.70-$6.00 and said it forecasts 2018 GAAP diluted EPS of $4.55-$4.85, which now includes an estimate of currently known and anticipated CEO transition costs of 23c per share. 3. Led by Tilray (TLRY), the U.S.-listed grower that went public in July, the shares of Canada's pot producers skyrocketed by Wednesday and then gave most of their gains back, raising comparisons between marijuana stocks and the Bitcoin bubble, Bill Alpert wrote in this week's edition of Barron's. Canada's licensed marijuana producers begin recreational sales on October 17 and they have acres of greenhouses in bloom, but their stock prices have been weakly tethered to business fundamentals for months now, and last week's blow-off was all the proof needed that the trading has become irrational, Alpert contended. 4. Comcast subsidiary Universal's "The House With a Clock in its Walls" debuted to a better than expected $26.9M from 3,592 theaters, topping the chart. Overseas, the pre-Halloween offering that follows a young orphan who goes to live in his uncle's spooky house launched to $8.7M for a global start of $35.6M. The movie earned a B+ CinemaScore and sports a 68% Rotten Tomatoes score. 5. Boston Scientific (BSX), Intuitive Surgical (ISRG), Caterpillar (CAT), Applied Materials (AMAT), BorgWarner (BWA), KeyCorp (KEY), Parker-Hannifin (PH), Apple (AAPL), Cisco Systems (CSCO), Intel (INTC), IBM (IBM), Microsoft (MSFT), Oracle (ORCL), and Berkshire Hathaway (BRK.A, BRK.B) saw positive mentions in Barron's.

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SKYAY

Sky

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

RBC

Regal Beloit

$85.80

-0.25 (-0.29%)

TLRY

Tilray

$123.16

-53.365 (-30.23%)

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

INTC

Intel

$46.64

-0.56 (-1.19%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

BRK.B

Berkshire Hathaway

$220.57

-1.24 (-0.56%)

  • 23

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 29

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 09

    Oct

  • 10

    Oct

  • 18

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 28

    Nov

  • 03

    Mar

CMCSA Comcast
$37.91

0.1 (0.26%)

09/18/18
LOOP
09/18/18
NO CHANGE
Target $125
LOOP
Buy
Disney expected to acquire Sky through Fox, says Loop Capital
Loop Capital analyst Alan Gould kept his Buy rating and $125 price target on Disney (DIS), saying he continues to expect the company to acquire Sky (SKYAY) through Fox (FOXA) ahead of the 5-day auction process that may begin next week. The analyst believes that Disney "can afford to overpay" for the assets that he deems to be "strategically important" to its global DTC business and expects Fox to raise its Sky bid to "at least" match the GBP14.75 per share offer from Comcast (CMCSA). Gould also raises his expected Disney FY18 EPS view by 2c to $6.95 to account for strong film results in the current quarter.
09/20/18
JEFF
09/20/18
NO CHANGE
Target $44
JEFF
Buy
Jefferies boosts Comcast target to $44, reiterates as top-pick
Jefferies analyst John Janedis raised his price target for Comcast to $44 from $41 and reiterates the shares as a top-pick with a Buy rating. Sentiment on the stock should continue to improve as broadband subscriber growth and average revenue per user "remains healthy," fixed 5G is viewed as a less viable threat and as Business Services "remains a growth engine," Janedis tells investors in a research note titled "Trends in Cable Reinforce Our Positive View." He views Comcast's portfolio of assets as "unique" and believes the M&A overhang "should begin to diminish" as the Sky (SKYAY) process concludes.
08/06/18
08/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Overweight from Neutral at Atlantic Equities with analyst Hamilton Faber saying he believes "the bulk of the M&A storm" has passed. 2. Qualcomm (QCOM) upgraded to Outperform from Market Perform at Cowen with analyst Matthew Ramsay citing the company's $30B buyback and saying he believes the shares offer a compelling risk/reward with effects of lower spending, solid customer performance, and potential QTL resolutions. 3. Square (SQ) upgraded to Buy from Neutral at Buckingham with analyst Chris Brendler saying the Q2 strong results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better-then-expected core revenue growth into 2020. 4. Parker-Hannifin (PH) upgraded to Outperform from In Line at Evercore ISI with analyst David Raso saying the company's recent operational struggles are behind it with this quarters report and views 2019 guidance as conservative. 5. Intercept (ICPT) upgraded to Buy from Sell at Goldman Sachs with analyst Salveen Richter saying Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/18
UBSW
09/19/18
DOWNGRADE
UBSW
Neutral
Sky downgraded to Neutral from Buy at UBS
UBS downgraded Sky (SKYAY) to Neutral while raising its price target for the shares to 1,600p from 1,500p. The firm cites valuation for the downgrade with the stock up over 70% in the last 12 months. Sky shares are pricing in high probability that Disney (DIS)/Fox (FOXA) will return with a higher offer, UBS says. It continues to believe the company is "strategically valuable" to both Disney/Fox and Comcast (CMCSA).
CMCSK Comcast
$0.00

(0.00%)

07/25/18
JPMS
07/25/18
NO CHANGE
JPMS
Overweight
Invalidated patent 'not material' to TiVo court fight, says JPMorgan
JPMorgan analyst Sterling Auty noted that the USPTO's Patent Trial and Appeal Board has declared patent 8,433,696 held by TiVo (TIVO) to be invalid as it believes that the technology involves a variation of earlier know-how. While a "scary headline," the reality is this does not matter in terms of TiVo's court case with Comcast (CMCSA), since this patent was dropped from the case, said Auty, who keeps an Overweight rating on TiVo shares.
07/13/18
07/13/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. VF CORP DOUBLE UPGRADE: BofA Merrill Lynch analyst Robert Ohmes upgraded VF Corp (VFC) to Buy from Underperform and raised his price objective to $96 from $65 ahead of the company's earnings report on July 20, telling investors in a research note that he believes Vans will be a "go-to-brand" for the back-to-school selling season. He said his channel checks indicate accelerating momentum in Vans, especially classic styles, and that the $50-$60 price point is attractive given consumers' shift to value. RAYMOND JAMES DOWNGRADES AT&T: Raymond James downgraded AT&T (T) to Market Perform from Outperform. Analyst Frank Louthan said he views the Department of Justice appeal of the Time Warner case as a negative and said it is a "frustrating delay." Louthan expects the suit to be a "significant overhang" for an extended period of time, which will limit share appreciation, but remains confident AT&T will prevail. AT&T is lower by 2% in late morning trading. STIFEL STARTS GALMED WITH A BUY: Stifel analyst Adam Walsh initiated Galmed (GLMD) with a Buy rating and $35 price target, calling it a "legitimate late-stage NASH play" after Aramchol recently proved itself in a Phase 2 trial as a clearly active and "very safe" compound for treating NASH. Galmed is trading higher by over 17% in late morning trading. MORGAN STANLEY HIKES WWE TARGET TO $100: Morgan Stanley analyst Benjamin Swinburne said that WWE (WWE), by securing rights fees in its new five-year agreements with NBC (CMCSA, CMCSK) and Fox (FOX, FOXA) that are 3.6 times higher than its prior five-year broadcast agreement with NBC, has gained a "massive increase" in earnings power and "extremely high" visibility into the associated revenue. Given the recently announced deals, he raised his price target on WWE shares to $100 from $58 and kept an Overweight rating on the stock. WILLIAM BLAIR CALLS KEMPER PULLBACK 'BUYING OPPORTUNITY': William Blair analyst Adam Klauber said he views shares of Kemper (KMPR) as "even more attractive" after the recent pullback, which he attributes to selling pressures from Infinity Property shareholders receiving Kemper stock. Klauber said Kemper "continues to be our top conviction idea," and kept an Outpeform rating on the name. Kemper is higher by 4.8% in late morning trading.
06/26/18
BUCK
06/26/18
INITIATION
BUCK
Neutral
Sky initiated with a Neutral at Buckingham
Earlier today, Buckingham analyst Michael Harrigan initiated Sky (SKYAY) with a Neutral rating and GBP14.50 price target with 3% upside, above Comcast's (CMCSA) GBP12.50 cash bid and a premium to 21st Century Fox's (FOXA) GBP10.75 bid to buy the 61% of Sky it does not already own. The analyst tells investors in a research note that a higher bid assessment could be triggered by the U.K. Takeover Panel exercising its authority to mandate a higher takeout bid if the price paid by Comcast or Disney (DIS) to buy the 21st Century Fox assets that are in play implies a higher bid.
07/13/18
BERN
07/13/18
NO CHANGE
BERN
Bernstein 'not so sure' Comcast will give up on Fox assets
Bernstein analyst Todd Juenger said that it appears that the market is starting to believe Comcast (CMCSA) will give up on its bid to buy assets from 21st Century Fox (FOXA) and focus on Sky (SKYAY), but he said he is "not so sure" that is the case after only one counter from Disney (DIS). He does not believe Comcast would put forth a $35 bid unless it was prepared to bid up to near $45 per share, Juenger tells investors. If Comcast ups its bid, it either wins Fox at a high price or Disney is forced to pay more, which both seem better than giving up to him, Juenger stated. In any case, the "winner" will be left with increased leverage on a cyclical business late in the cycle at a time when it needs to invest significantly to build its direct-to-consumer business, added Juenger.
SKYAY Sky
$0.00

(0.00%)

07/20/18
JEFF
07/20/18
NO CHANGE
Target $41
JEFF
Buy
Comcast added to Franchise Pick List with $41 target at Jefferies
Jefferies analyst John Janedis added Comcast (CMCSA) to his firm's Franchise Pick List while keeping a Buy rating on the shares with a $41 price target. The analyst expects the "M&A driven volatility" to subside following Comcast's announcement to walk away from 21st Century Fox (FOXA). The stock remains attractively valued with the company's fundamentals "stable to improving," Janedis tells investors in a research note. He believes the outcome of Sky (SKYAY) "will not be a thesis changer" and that Comcast should see multiple expansion.
FOX 21st Century Fox
$43.97

-0.23 (-0.52%)

08/09/18
08/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Seagate (STX) downgraded to Sell from Neutral at Goldman Sachs by analyst Mark Delaney, who said that while Seagate has improved its product offerings in the last few years, hard disk drives remain a cyclical industry, and one "facing secular challenges in many parts of the market." 2. 21st Century Fox (FOXA) downgraded to Sector Perform from Outperform at RBC Capital by analyst Steven Cahall who noted that the stock is now trading near its M&A price and that he does not see any competitive bids emerging. 3. e.l.f. Beauty (ELF) downgraded to Hold from Buy at Jefferies by analyst Stephanie Wissink, who said she is disappointed with the company's "sales fall off," which she says "seems more systemic than previously assumed." e.l.f.'s profit advancement will reverse in the second half of the year amid stepped up brand investment. Shares were also downgraded to Underweight from Neutral at Piper Jaffray, who said she sees a "growing risk of shelf-space cuts into 2019" if underlying sales trends do not improve, at Citi to Neutral from Buy and at DA Davidson to Neutral from Buy. 4. Southern Company (SO) downgraded to Underperform from In Line at Evercore ISI by analyst Greg Gordon, who said he believes the shares are still not discounting enough risk after the company announced a $790M after-tax charge related to an increase in the cost estimate for constructing Vogtle Nuclear Plants 3 and 4. Shares were also downgraded to Underperform from Neutral at Credit Suisse, to Equal Weight from Overweight at Barclays and to Neutral from Buy at Guggenheim. 5. Schneider National (SNDR) downgraded to Underperform from Buy at BofA/Merrill by analyst Ken Hoexter, who cited "stretched" relative valuation. The analyst also downgraded Genesee & Wyoming (GWR) to Neutral from Buy, saying recent strength in shares has led to a premium multiple and sees minimal upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/09/18
08/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN CUTS SEAGATE TO SELL: Goldman Sachs analyst Mark Delaney downgraded Seagate Technology (STX) to Sell from Neutral and lowered his price target for the shares to $44 from $50, representing 20% downside from current levels. While Seagate has improved its product offerings in the last few years, hard disk drives remain a cyclical industry, and one "facing secular challenges in many parts of the market," Delaney said. He believes Seagate's fundamentals will peak in the second half of 2018 and decline in 2019. RBC CUTS FOX TO SECTOR PERFORM ON VALUATION: RBC Capital analyst Steven Cahall downgraded 21st Century Fox (FOXA) to Sector Perform from Outperform, but raised his price target to $49 from $45. The analyst noted that the stock is now trading near its M&A price and that he does not see any competitive bids emerging. Cahall adds that while the company is "undervalued", he awaits the separation to re-evaluate his stance. MORGAN STANLEY DOWNGRADES SEMI INDUSTRY: Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore kept Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. SOUTHERN COMPANY GETS MULTIPLE DOWNGRADES AFTER Q2 REPORT: Barclays analyst Eric Beaumont downgraded Southern Company (SO) to Equal Weight and lowered his price target for the shares to $48 from $51. Credit Suisse analyst Michael Weinstein downgraded Southern Company to Underperform from Neutral and lowered his price target on the shares to $43 from $46. Guggenheim analyst Shahriar Pourreza downgraded Southern Company to Neutral from Buy and lowered his price target on the stock to $47 from $50. Evercore ISI analyst Greg Gordon downgraded Southern Company to Underperform from In Line and lowered his price target on Southern shares to $46 from $46.75.
FOXA 21st Century Fox
$44.33

-0.26 (-0.58%)

RBC Regal Beloit
$85.80

-0.25 (-0.29%)

02/07/18
GHSC
02/07/18
UPGRADE
GHSC
Buy
Regal Beloit upgraded to Buy at Seaport Global
As previously reported, Seaport Global upgraded Regal Beloit to Buy from Neutral and raised its price target to $88 from $82. Analyst Walt Liptak said Regal raised its 2018 outlook due to expectations that the price/cost situation will improve. Liptak expects rising copper and steel prices will result in positive operating leverage and self-help programs will result in incremental profit improvements.
06/27/18
WOLF
06/27/18
INITIATION
Target $97
WOLF
Outperform
Regal Beloit initiated with an Outperform at Wolfe Research
Wolfe Research initiated Regal Beloit with an Outperform and price target of $97.
03/29/18
BARD
03/29/18
NO CHANGE
Target $89
BARD
Outperform
Regal Beloit elevated to Fresh Pick status at Baird
Baird analyst Michael Halloran raised Regal Beloit to Fresh Pick status following positive management meetings. The analyst noted management feels comfortable with Q2 guidance and cited its price increase, investment initiatives and healthy near-term demand. Halloran reiterated his Outperform rating and $89 price target on Regal Beloit shares.
02/15/18
LEHM
02/15/18
INITIATION
Target $80
LEHM
Equal Weight
Regal Beloit initiated with an Equal Weight at Barclays
Barclays analyst Julian Mitchell started Regal Beloit with an Equal Weight rating and $80 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
TLRY Tilray
$123.16

-53.365 (-30.23%)

09/06/18
NORL
09/06/18
DOWNGRADE
NORL
Market Perform
Tilray downgraded to Market Perform from Outperform at Northland
09/06/18
09/06/18
DOWNGRADE

Market Perform
Tilray downgraded to Market Perform after 'massive' move up at Northland
As previously reported, Northland analyst Mike Grondahl downgraded Tilray to Market Perform from Outperform. While he continues to see the company playing a "huge role" in the recreational-use cannabis market in Canada and other countries and the medical market in Europe, he also believes the risk/reward is far more balanced following the recent "massive" move in the stock. Though he lowered his rating, Grondahl also sees optionality for Tilray from other new markets, including potentially the U.S. someday, he noted.
09/06/18
09/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ANALYSTS WEIGH IN ON MICRON: Despite recent softness in DRAM spot pricing, the more appropriate metric for Micron Technology (MU) investors to focus on is gross margin, Deutsche Bank analyst Sidney Ho said. On gross margin, the analyst sees Micron benefiting from "solid cost improvement through technology transition" in fiscal 2019. Further, he believes the DRAM market has become more diverse, which should help offset temporary weakness in any given end market. As the company continues to execute on its technology roadmap and delivers solid operating results, Ho expects Micron's stock valuation to re-rate. He kept a Buy rating and $80 price target on Micron. However, Baird analyst Tristan Gerra said Micron is no longer a top large-cap idea, citing its valuation and the likelihood gross margins may be nearing their peak. He also noted DRAM pricing is likely peaking and NAND is in significant oversupply. Gerra maintained an Outperform rating but lowered his price target to $75 from $100 on Micron shares. ARGUS UPGRADES PG&E TO BUY: Argus analyst Jacob Kilstein upgraded PG&E (PCG) to Buy from Hold with a price target of $54, saying the company's recent California legislative victory will reduce its liability for last year's wildfire as its earnings outlook improves. Kilstein further anticipates PG&E to announce a timeline regarding its dividend reinstatement after being forced to suspend its quarterly payout on concerns about its potential wildfire damage responsibility estimated as high as $12B. NORTHLAND DOWNGRADES TILRAY TO MARKET PERFORM: Northland analyst Mike Grondahl downgraded Tilray (TLRY) to Market Perform from Outperform. While he continues to see the company playing a "huge role" in the recreational-use cannabis market in Canada and other countries and the medical market in Europe, he also believes the risk/reward is far more balanced following the recent "massive" move in the stock. JPMORGAN CUTS FRANKLIN RESOURCES TO UNDERWEIGHT: JPMorgan analyst Kenneth Worthington downgraded Franklin Resources (BEN) to Underweight from Neutral and lowered his price target for the shares to $29 from $32. The analyst believes the more recent weakness in emerging markets, and in particular in emerging market debt, will weigh on both Franklin's organic growth and earnings potential. He thinks challenges in emerging markets put additional pressure on "an already challenging growth story characterized by weak fund performance, significant outflows, and declining margins." Worthington continues to have a negative view on the asset management sector.
09/20/18
STFL
09/20/18
NO CHANGE
STFL
Top 22 Canadian cannabis stocks up 127% since Constellation pact, says Stifel
Yesterday's significant outperformance for Canadian cannabis stocks, led by Tilray (TLRY), at one point pushed the total market capitalization for Canadian Licensed Producers above $C80B, before they closed with a combined market cap of C$73B, calculates Stifel analyst Christopher Growe. Since August 15, when Constellation Brands (STZ) announced a pact to invest C$5B into Canopy Growth (CGC), the top 22 Canadian cannabis stocks are up 127% in stock price, noted Growe. A $C73B market cap in relation to what he estimates to be an addressable Canadian market of C$10B is "difficult to fathom," so valuations require global opportunities to be realized, added Growe, who said he questions the pace of development and degree of advantage for these companies. Companies in the cannabis space that can be traded in the U.S. include Aurora Cannabis (ACBFF), CV Sciences (CVSI), Canopy Growth, Cronos Group (CRON) and Tilray.
BSX Boston Scientific
$37.76

-0.07 (-0.19%)

09/04/18
09/04/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Strong Buy from Market Perform at Raymond James with analyst Patrick Tyler Brown saying he believes investors are underappreciating UPS' long-term Domestic EBIT and 2021 free cash flow outlook, which could be greater than $8B. 2. Qualcomm (QCOM) upgraded to Outperform from Neutral at Macquarie with analyst Srini Pajjuri saying he believes risk/reward is attractive and sees multiple catalysts ahead including a final settlement with Huawei in the near future, increasing probability of an Apple (AAPL) settlement, and a 5G cycle that is not fully reflected in consensus estimates. 3. Albemarle (ALB) upgraded to Buy from Hold at SunTrust with analyst James Sheehan saying investors have driven down the price of the stock amid lithium oversupply concern on incorrect assumption that it is a commodity. 4. Univar (UNVR) upgraded to Buy from Hold at Berenberg with analyst Thomas Burlton saying the company is improving its conversion margin and EBITDA growth while its cash generation is also getting better. 5. Boston Scientific (BSX) upgraded to Buy from Hold at Jefferies with analyst Raj Denhoy citing a survey of 25 U.S. transcatheter aortic valve replacement doctors to gauge interest in tBoston Scientific's Lotus value. While feedback was better for Edwards Lifesciences (EW) and Medtronic's (MDT) valves, the majority of respondents were still interested in trying Lotus and expected the valve to capture 16%-18% share of the market. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/04/18
JEFF
09/04/18
UPGRADE
Target $42
JEFF
Buy
Jefferies upgrades Boston Scientific to Buy after TAVR doctor survey
Jefferies analyst Raj Denhoy upgraded Boston Scientific (BSX) to Buy from Hold and raised his price target for the shares to $42 from $34. He upgraded the shares after surveying 25 U.S. transcatheter aortic valve replacement doctors to gauge interest in tBoston Scientific's Lotus value. While feedback was better for Edwards Lifesciences (EW) and Medtronic's (MDT) valves, the majority of respondents were still interested in trying Lotus and expected the valve to capture 16%-18% share of the market, Denhoy tells investors in a research note. He notes that by 2022, the U.S. TAVR market is expected to be $3.1B and the global market $6.5B. Boston Scientific's revenue growth can be sustained at 7% through at least 2022, Denhoy writes. That level of growth keeps Boston Scientific at the upper end of medtech growth and supports a positive view on the stock, the analyst adds.
09/10/18
NEED
09/10/18
NO CHANGE
Target $43
NEED
Strong Buy
Boston Scientific price target raised to $43 from $39 at Needham
Needham analyst Mike Matson raised his price target on Boston Scientific to $43 and kept his Strong Buy rating. The analyst cites the company's latest $500M bid Augmenix, whose SpaceOAR reduces side effects associated with prostate radiotherapy. While the company expects "immaterial" earnings impact from the deal through 2019, Matson believes that it will strengthen its Urology & Pelvic Health business longer term, with added potential "revenue synergies given BSX's NxThera acquisition and legacy GreenLight XPS system".
09/05/18
ARGS
09/05/18
NO CHANGE
Target $41
ARGS
Buy
Boston Scientific price target raised to $41 from $36 at Argus
Argus analyst Jasper Hellweg raised his price target on Boston Scientific to $41 and kept his Buy rating, saying the company's outperformance over the past 3 months has been driven by its new product and acquisition news. Hellweg further cites the company's Q2 results showing organic sales growth up in all 3 of its sectors and across all regions. The analyst also notes that the stock price is trading in a bullish pattern of higher lows and highs going back to 2012 and believes that Boston Scientific is deserving of its premium valuation based on its growth outlook and profitability profile.
ISRG Intuitive Surgical
$556.70

-4.43 (-0.79%)

09/13/18
PIPR
09/13/18
NO CHANGE
PIPR
Piper sees minimal impact to Medtech space from Hurricane Florence
Piper Jaffray analyst Matt O'Brien says he's heard investor concerns over the impact on Medtech companies with Hurricane Florence set to impact the Carolinas in the next 48 hours. While the analyst anticipates some delays, he believes the overall impact to the space will be minimal, ranging between 10-60 basis points of Q3 revenue for most companies in the region. On the supply-side, Teleflex (TFX), Baxter (BAX), Merit Medical (MMSI), and Intuitive Surgical (ISRG) have the most manufacturing and distribution exposure in North Carolina, South Carolina, Georgia and Virginia, O'Brien tells investors in a research note. However, the analyst adds that many of these locations could be unaffected depending on the storm's path. He believes any hurricane-related weakness in the Medtech shares is likely to be transient and "potentially provide more attractive entry points."
09/12/18
WELS
09/12/18
NO CHANGE
Target $635
WELS
Outperform
Intuitive Surgical price target raised to $635 from $575 at Wells Fargo
Wells Fargo analyst Lawrence Biegelsen raised his price target for Intuitive Surgical to $635 from $575 on his 2020 EPS estimate, which represents a premium to the large cap medtech peers. The analyst notes that the company has filed a complaint against Auris Health, alleging that the company's Monarch endoscopy platform that received FDA 510k clearance on March 22 infringes on eight patents held by Intuitive. It further alleges that Monarch will compete directly with Intuitive's Flex platform that is awaiting FDA clearance for use in lung biopsies, Biegelsen adds. After his patent consultant reviewed the complaints, the analyst believes Intuitive's case may be weak, but is not likely to have an impact on the company given that the underlying markets are large and underserved with room for both competitors. He reiterates an Outperform rating on Intuitive shares.
07/20/18
STFL
07/20/18
NO CHANGE
Target $600
STFL
Buy
Intuitive Surgical price target raised to $600 from $515 at Stifel
Stifel analyst Rick Wise said Intuitive Surgical "emphatically checked every important box" with its Q2 report, noting that its procedures growth, systems shipments, and EPS all meaningfully topped expectations. Following the report, he raised his 2018-2020 sales and EPS projections and increased his price target on the stock to $600. Wise keeps a Buy rating on Intuitive shares.
07/20/18
MSCO
07/20/18
NO CHANGE
Target $575
MSCO
Overweight
Intuitive Surgical price target increased to $575 from $535 at Morgan Stanley
Morgan Stanley analyst David Lewis increased his price target on Intuitive Surgical to $575 from $535, stating that "inflection in the core is evident" given the better than expected procedure growth and system upside reported in Q2. With trends in procedures and systems strong, he is confident in growth sustainability and he is additionally confident that Intuitive will not only to maintain technological leadership but materially expand its addressable market with new introductions, Lewis tells investors. He maintains an Overweight rating on Intuitive shares.
CAT Caterpillar
$156.39

0.38 (0.24%)

09/20/18
BMOC
09/20/18
NO CHANGE
Target $185
BMOC
Outperform
Meetings with Caterpillar management 'cat-agorically bullish', says BMO Capital
BMO Capital analyst Joel Tiss kept his Outperform rating and $185 price target on Caterpillar after meeting with its head of Resource Industries and representatives from Investor Relations this week, saying the discussions affirmed his view that the company's "cyclical peak concerns are overblown". Tiss notes that Caterpillar's end markets are not expected to top out for "several years", with mining and energy starting to show some traction from the bottom and power generation also showing signs of recovery. The analyst adds that the management looks ahead to a "significant opportunity in driving growth in its existing business" as it transitions from cost reductions to improved profitability.
09/20/18
09/20/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BAIRD UPGRADES CATERPILLAR TO OUTPERFORM: Baird analyst Mig Dobre upgraded Caterpillar (CAT) to Outperform from Neutral. The analyst believes demand growth should continue into 2019. While some markets like China are close to peak, most of its demand is still at or below mid-cycle levels, said Dobre, who raised his price target to $191 from $155 on Caterpillar shares. Caterpiller is up 1.5% in late morning trading. PIPER CUTS STITCH FIX TO NEUTRAL: Piper Jaffray analyst Erinn Murphy downgraded Stitch Fix (SFIX) to Neutral while raising her price target for the shares to $43 from $29. The analyst cited valuation for the downgrade. With shares nearing $50, market expectations do not provide any margin of error, Murphy said. She believes the "smallest hint" of pressure could be a significant negative catalyst for the stock. Further, the analyst notes that Amazon's (AMZN) Prime Wardrobe is now advertising in key NFL slots and that the company is testing a personalized recommendation service for certain categories. In late morning trading, Stitch Fix is lower by over 13%. COWEN CUTS SKECHERS TO MARKET PERFORM: Cowen analyst John Kernan downgraded Skechers (SKX) to Market Perform from Outperform citing growing inventory levels, particularly as foreign exchange headwinds in key markets build. He also believes consensus forecasts for operating expansion are too optimistic. Kernan lowered his price target to $28 from $32 on Skechers shares, which are down 4.7% in late morning trading. JPMORGAN CUTS GE'S PRICE TARGET: JPMorgan analyst Stephen Tusa lowered his price target for General Electric (GE) to $10 from $11 and kept an Underweight rating on the shares. The impact on "asset value" from a failure at GE's U.S. H-frame launch customer, while tough to estimate, represents a negative development for a company that has little wiggle room for more "shoes to drop," Tusa said. MORGAN STANLEY POSITIVE ON APPLE IPHONE DUAL-SIM ADDITION: In EMEA and Asia, smartphones with dual-SIM capabilities have become the status quo, noted Morgan Stanley analyst Katy Huberty, who believes that Apple adding dual-SIM to the new iPhones is an underappreciated feature with the potential to drive upside to shipments in FY19. Huberty kept an Overweight rating and $247 price target on Apple shares.
09/20/18
09/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ralph Lauren (RL) upgraded to Neutral from Underweight at Piper Jaffray with analyst Erinn Murphy, who remains concerned about the sustainability of Ralph Lauren's sales group, saying earnings estimates are likely to continue to grind higher given the company's "sound" cost control and favorable margin mix shift. 2. Caterpillar (CAT) upgraded to Outperform from Neutral at Baird with analyst Mig Dobre saying he believes demand growth should continue into 2019. 3. Copart (CPRT) upgraded to Buy from Hold at Gabelli with analyst Matthew Paige saying he raised his valuation multiple to 15x EBITDA from 12x to reflect the premium he believes the stock deserves relative to KAR Auction Service (KAR) given its EBITDA margin advantage and his view that current market conditions better support the salvage auction business than wholesale. 4. Arcturus Therapeutics (ARCT) upgraded to Strong Buy from Buy at WBB Securities. 5. First BanCorp (FBP) upgraded to Buy from Neutral at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/18
OTRG
09/21/18
DOWNGRADE
OTRG
Mixed
Caterpillar downgraded to Mixed from Positive at OTR Global
AMAT Applied Materials
$39.62

0.22 (0.56%)

09/12/18
GSCO
09/12/18
DOWNGRADE
Target $180
GSCO
Neutral
Lam Research downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Toshiya Hari downgraded Lam Research (LRCX) to Neutral and lowered his price target for the shares to $180 from $224. The analyst also lowered his coverage view on the Semiconductor Capital Equipment space to Neutral from Attractive. Hari reduced his 2018/2019 memory capex expectations following "early signs of excess supply" in DRAM combined with further weakness in NAND pricing. The group, namely Applied Materials (AMAT), Lam Research and KLA-Tencor (KLAC), has underperformed the indexes year-to-date, but the stocks are still up 140% on average off the lows in September 2015 and have outperformed the broader market by 90% during this timeframe, Hari tells investors in a research note. While the analyst was initially hopeful that Samsung's (SSNLF) decision to push out DRAM spending was specific to the company and related to node transition issues as opposed to supply/demand issues, he now envisions a more "broad-based correction" in memory capex in 2019, as memory manufacturers digest excess capacity in NAND and to a lesser extent DRAM. Hari, however, continues to view Lam as one of the best managed companies in his coverage universe and a long-term share gainer. He just believes the stock is unlikely to outperform our broader coverage group amid negative estimate revisions.
08/28/18
08/28/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. APPLIED MATERIALS, LAM RESEARCH CUT TO NEUTRAL: BofA Merrill Lynch analyst Vivek Arya downgraded both Lam Research (LRCX) and Applied Materials (AMAT) to Neutral from Buy after lowering his wafer fab equipment growth outlook for this year to up 7% from up 10%. Arya also cut his estimates for 2019 and 2020, primarily to account for lower memory capital expenditures. He now expects relative growth in foundry/logic paired with declines in memory within the context of a "muted" WFE recovery in 2019. He lowered his price target on Applied shares to $49 from $65 and cut his target on Lam shares to $200 from $235. In late morning trading, Lam Research is down 2.5%, while Applied Materials is down 1%. BAIRD UPGRADES XILINX TO OUTPERFORM: Baird analyst Tristan Gerra upgraded Xilinx (XLNX) to Outperform from Neutral. The analyst said his field research suggests a very recent and significant acceleration in 5G-related orders for FPGAs scheduled for later this year. He also said data centers represent a longer-term significant growth avenue for the company. Gerra raised his price target to $90 from $71 on Xilinx shares. Xilinx is more than 2% higher in late morning trading. MORGAN STANLEY UPS COTY TO OVERWEIGHT: Morgan Stanley analyst Dara Mohsenian upgraded Coty (COTY) to Overweight from Equal Weight, pointing out that this is the first time the firm has had an Overweight rating on the stock since the company's 2013 IPO. Following four sell-side downgrades in the last two weeks and the stock's 40% year-to-date decline, Mohsenian now sees the risk/reward as "compelling," he told investors. Mohsenian, however, trimmed his price target on Coty shares to $14.50 from $17.00. Shares of Coty are up 6.6% in late morning trading. MORGAN STANLEY DISCUSSES MICROSOFT DIVIDEND RAISE: Morgan Stanley analyst Keith Weiss noted that Microsoft (MSFT) typically announces a dividend raise in mid-September and pointed out that the company has raised its dividend by an average of 14% annually since the financial crises in 2009, when the dividend was unchanged. He sees a higher probability of an above average dividend raise in September, noting that an increase of over 20% constitutes a raise larger than "normal" and would allow the dividend yield to return to above 2% despite strong stock performance over the last year. Weiss maintained his Overweight rating and $130 price target on Microsoft shares.
08/28/18
08/28/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mitek Systems (MITK) downgraded to Hold from Buy at Benchmark with analyst Mark Schappel saying recent management departures leave uncertainty in key roles. 2. Control4 (CTRL) downgraded to In-Line from Outperform at Imperial Capital with analyst Saliq Khan citing valuation. 3. Applied Materials (AMAT) and Lam Research (LRCX) were downgraded to Neutral from Buy at BofA/Merrill. 4. DDR Corp. (DDR) downgraded to Hold from Buy at Deutsche Bank. 5. Newtek Business Services (NEWT) downgraded to Underperform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/10/18
STFL
09/10/18
NO CHANGE
STFL
Stifel maintains near-term outlook on WFE despite KLA-Tencor comments
Stifel analyst Patrick Ho attributes last week's sharp selloff in semiconductor capital equipment stocks to comments made by KLA-Tencor's (KLAC) management regarding additional push-outs coming from the DRAM space. Following KLA-Tencor comments that DRAM suppliers had "pushed out" the timing of some initial tool deliveries into the first half of calendar 2019, Ho said his checks suggest that these push outs are coming from multiple players, one of which had already been hinted at earlier. Given potential DRAM push outs, some of which were already factored into his current forecast, Ho believes 2018 WFE could end up between $48-$50B, which he notes would be up slightly from $47.5B in 2017. For 2019, his current WFE forecast calls for $53B-$55B, or up 5%-10%, which Ho said he will maintain for now. His preferred semi capital equipment names are Applied Materials (AMAT), MKS Instruments (MKSI) and Ichor Holdings (ICHR), on all of which Ho has Buy ratings. Others in the space include Lam Research (LRCX), ASML (ASML), Teradyne (TER) and Kulicke & Soffa (KLIC).
BWA BorgWarner
$45.24

-0.53 (-1.16%)

09/19/18
RBCM
09/19/18
NO CHANGE
Target $49
RBCM
Outperform
BorgWarner price target lowered to $49 from $55 at RBC Capital
RBC Capital analyst Joseph Spak lowered his price target on BorgWarner to $49 after its Analyst Day presentation yesterday, where it lowered its 2018 organic growth expectations to 4.5%-5.5% from 6%-7%. The analyst says the Q3 outlook for organic growth of 3.0%-3.5% implies Q4 outlook of 1%-5% growth range and reflects uncertainty around China production at the end of the year. Longer term, the analyst is positive on the company's expected market share gains in hybrid and battery electric vehicles, keeping his Outperform rating on BorgWarner.
07/18/18
WELS
07/18/18
UPGRADE
Target $56
WELS
Outperform
BorgWarner upgraded to Outperform on upside potential at Wells Fargo
As previously reported, Wells Fargo analyst Richard Kwas upgraded BorgWarner to Outperform from Market Perform as he sees limited share price downside risk and disproportionate upside potential from the current share price. The company will host an investor day in mid-September, which he thinks could be a positive catalyst. Specifically, the analyst believes BorgWarner will increase its estimates for hybrid and electric content per vehicle and outline more robust growth potential from vehicle electrification. Kwas also trimmed his price target on the shares to $56 from $57.
07/18/18
07/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comerica (CMA) upgraded to Outperform from In Line at Evercore ISI with analyst John Pancari saying he expects earnings growth to outpace peers while returns continue to strengthen, supported by a favorable positioning for higher short-term rates, ongoing efficiency improvement, and intact credit. 2. BorgWarner (BWA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Richard Kwas saying he sees limited share price downside risk and disproportionate upside potential from the current share price. 3. Avon Products (AVP) upgraded to Hold from Underperform at Jefferies with analyst Stephanie Wissink saying she believes shares of Avon are close to fair value. 4. Sunoco (SUN) upgraded to Hold from Underperform at Jefferies with analyst Christopher Sighinolfi saying while he still expects a 30% distribution cut and "equity needs" resulting from elevated leverage, he no longer sees "sufficient downside" with the shares down 10% since early April. 5. CSX (CSX) upgraded to Buy from Hold at Loop Capital with analyst Rick Paterson saying CSX is making "continued progress on the adoption of its scheduled operating model," delivering an operating ratio of 59.8% in Q2 vs. 64.7% last year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, Reference Link
07/23/18
OPCO
07/23/18
NO CHANGE
Target $58
OPCO
Outperform
BorgWarner price target lowered to $58 from $63 at Oppenheimer
Oppenheimer analyst Colin Rusch lowered his price target for BorgWarner to $58 from $63 on a lower valuation multiple. The analyst reiterates an Outperform rating on the shares.
KEY KeyCorp
$20.78

0.02 (0.10%)

06/26/18
ARGS
06/26/18
INITIATION
Target $24
ARGS
Buy
KeyCorp initiated with a Buy at Argus
Argus analyst Stephen Biggar initiated KeyCorp with a Buy rating and a price target of $24, saying the company's earnings trend should outpace that of its peers thanks to its positive loan growth, net interest margin expansion, and strong credit quality. The analyst is also positive on the impact of the regulatory rollback to Dodd-Frank Act toward the regional banking sector. Biggar states that his target on KeyCorp implies a 14-times PE valuation multiple and represents a "modest premium" to the 13-times average for its regional bank peers, which is justifiable by its growth profile as well as its better return on equity and efficiency ratio metrics.
06/29/18
DBAB
06/29/18
NO CHANGE
DBAB
Deutsche declares Wells Fargo, SunTrust, Huntington the CCAR winners
Deutsche Bank analyst Matt O'Connor views Wells Fargo (WFC), SunTrust (STI) and Huntington Bancshares (HBAN) as the winners of the Federal Reserve's Comprehensive Capital Analysis and Review. The banks separately disclosed planned dividend increases and buybacks for the next four quarters, O'Connor tells investors in a research note. He points out that while JPMorgan (JPM), KeyCorp (KEY) and M&T Bank (MTB) "all used the mulligan," he does not view this as negative.
06/29/18
WEDB
06/29/18
NO CHANGE
WEDB
Outperform
CCAR results 'very positive' for regional banks, says Wedbush
Wedbush analyst Peter Winter says the results of the CCAR for 2018 were "very positive" for the regional banks, as the average total capital return increased from 88% in the 2017 CCAR to 119%, above his forecast of 103%. In a research note to investors, Winter says the "winners" relative to his forecast were Regions Financial (RF), Huntington Bancshares (HBAN), Fifth Third (FITB), SunTrust (STI) and KeyCorp (KEY).
09/18/18
09/18/18
DOWNGRADE

Equal Weight
Morgan Stanley downgrades BankUnited to Equal Weight on midcap bank concerns
As previously reported, Morgan Stanley analyst Ken Zerbe downgraded BankUnited to Equal Weight from Overweight, stating that recent commentary from other midcap banks has been incrementally more negative. Five midcap banks - Associated Banc-Corp (ASB), Comerica (CMA), KeyCorp (KEY), M&T Bank (MTB) and Webster Financial (WBS) - have recently guided for loan growth below expectations and several others flagged headwinds to growth, Zerbe tells investors. The primary headwind is weaker CRE loan growth as non-bank lenders remain highly aggressive with both price and terms, the analyst added. BankUnited's CRE portfolio, at 43% of total loans versus peers at 27%, could be at greater risk of runoff, said Zerbe. He also reduced his expectations at 21 of 28 midcap banks he covers and cut his EPS estimates for 18 of those 28 banks.
PH Parker-Hannifin
$190.52

0.01 (0.01%)

09/06/18
LEHM
09/06/18
INITIATION
Target $200
LEHM
Overweight
Parker-Hannifin initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started Parker-Hannifin with an Overweight rating and $200 price target. With expectations having been reset, the valuation is near trough levels, Mitchell tells investors in a research note. The analyst sees further share underperformance as unlikely.
09/14/18
BUCK
09/14/18
UPGRADE
BUCK
Buy
Parker-Hannifin upgraded to Buy from Neutral at Buckingham
09/14/18
09/14/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Corning (GLW) upgraded to Buy from Neutral at Citi with analyst Asiya Merchant saying the shares are "poised to continue to grind higher" in the next 12-18 months as investors appreciate the company's "multiple vectors" for revenue growth, diversification and margin expansion. 2. Coca-Cola European Partners (CCE) was upgraded to Outperform at Wells Fargo and to Neutral from Negative at Susquehanna. 3. VF Corp. (VFC) upgraded to Outperform from Market Perform at Cowen with analyst John Kernan saying VF's disclosure of a 23% operating margin for Vans implies that the brand alone could generate $1B-plus in free cash flow by fiscal 2022. 4. Helmerich & Payne (HP) upgraded to Neutral from Underweight at JPMorgan with analyst Sean Meakim saying Helmerich exceeded his expectations in adapting to the upgrade cycle. 5. Parker-Hannifin (PH) upgraded to Buy from Neutral at Buckingham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/18
09/06/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Rite Aid (RAD) reinstated with a Sell at Goldman Sachs. 2. Parker-Hannifin (PH) initiated with an Overweight at Barclays. 3. iRhythm (IRTC) initiated with a Buy at Chardan. 4. Sarepta (SRPT) initiated with an Outperform at Credit Suisse. 5. Xperi (XPER) initiated with a Buy at National Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
AAPL Apple
$217.65

-2.35 (-1.07%)

09/21/18
NOMU
09/21/18
NO CHANGE
NOMU
Neutral
Qorvo content not yet showing up in iPhone teardowns, says Nomura Instinet
Publicly available teardowns released so far for Apple's (AAPL) iPhone XS and XS Max have not identified a Qorvo (QRVO) part in either of the flagship phones, according to Nomura Instinet analyst Krysten Sciacca, who called this "surprising." Sciacca, who said she would have expected to find an envelope tracker alongside the Intel (INTC) baseband, continues to believe Qorvo has won additional tuning/antenna content, "which has historically been difficult, if not nearly impossible, to identify from a board photo." She also thinks Qorvo likely has higher content in the lower-cost iPhone XR, which will be released next month. Sciacca has a Neutral rating on Qorvo shares.
09/20/18
BMOC
09/20/18
NO CHANGE
Target $219
BMOC
Market Perform
Apple price target raised to $219 from $199 at BMO Capital
BMO Capital analyst Tim Long raised his price target on Apple to $219, adjusting his unit shipments and margins model based on his updated analysis of its new iPhone line-up. The analyst lowers his FY19 forecast for shipments to 217M from 226M as he does not believe that the new line-up will lead to an iPhone upgrade cycle. Long sees the iPhone average selling price metric rising 17% in FY18 and another 6% in FY19, with the company postings its first increase in operating margins in four years next year and its gross margins rising to 38.8% from 38.4%. However, given his flat iPhone unit growth forecast and current valuation, the analyst keeps his Market Perform rating and sees Apple's risk-reward as balanced.
09/21/18
CHLM
09/21/18
NO CHANGE
CHLM
Craig-Hallum calls STMicro, Skyworks 'winners' from early iPhone teardowns
Craig-Hallum analyst Anthony Stoss said he believes STMicroelectronics (STM) is the largest beneficiary of content expansion across all three iPhone models, noting that the company's eSIM is being found in early iPhone teardowns, as expected. Stoss points out that likely only 25% of the chips are being identified in the initial teardown on the iPhone XS/XS Max and reminds investors that typically only one-third of all the chips in Apple's (AAPL) phones are ever identified. With that said, he called Skyworks (SWKS) the "other big winner." Stoss added that his projection that likely over 60% of total phone volumes will come from the lower-cost iPhone XR is something he views as a positive for both Synaptics (SYNA) and Qorvo (QRVO).
CSCO Cisco
$48.51

0.77 (1.61%)

09/07/18
PIPR
09/07/18
NO CHANGE
Target $250
PIPR
Overweight
Palo Alto Networks price target raised to $250 from $230 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target for Palo Alto Networks (PANW) to $250 saying the company last night reported strong Q4 results, exceeding the high-end of guidance by 3.6%. The analyst believes Palo Alto continues to "leverage the power of the platform," taking market share from both Cisco Systems (CSCO) and Check Point (CHKP). Nowinski thinks Palo Alto "still has a significant opportunity" for further share gains and he keeps an Overweight rating on the name.
09/11/18
PIPR
09/11/18
NO CHANGE
Target $50
PIPR
Overweight
Cisco Q1 product estimates may prove conservative, says Piper Jaffray
After reviewing Cisco's recently filed 10K, Piper Jaffray analyst James Fish said he believes Q1 product estimates may prove conservative given that the company's "impressive" product backlog of $6.6B represents about 69% of current product estimates, versus 53% on average. He also notes the 10K shows pricing only had a 1.4% negative impact to GAAP gross margins in FY18, which he contends shows "impressive product pricing discipline." Fish maintains an Overweight rating and $50 price target on Cisco shares.
08/27/18
GSCO
08/27/18
INITIATION
Target $15
GSCO
Neutral
Presidio initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Rod Hall started Presidio (PSDO) with a Neutral rating and $15 price target. The analyst views Presidio's "highly concentrated" vendor exposure as a potential positive in the near term as the Cat 9k cycle accelerates but negative in the medium to long term. He comes out on the sidelines saying Cisco Systems' (CSCO) ramping product cycle has so far evaded Presidio and the company's earnings record has been lackluster.
08/20/18
LOOP
08/20/18
NO CHANGE
Target $47
LOOP
Hold
Cisco price target raised to $47 at Loop Capital after 'solid' Q4
Loop Capital analyst James Kisner nudged his price target on Cisco to $47 after its "solid" Q4 result with the exception of continued softness in service provider routing. The analyst adds that while he is keeping his positive outlook on the company's strategic direction and execution, the current valuation given Cisco's "modest long-term growth prospects" is not sufficiently compelling for a more constructive stance. Kisner maintains his Hold rating on the shares.
INTC Intel
$46.64

-0.56 (-1.19%)

09/21/18
EVER
09/21/18
NO CHANGE
Target $80
EVER
Outperform
Micron price target lowered to $80 from $100 at Evercore ISI
Evercore ISI analyst C.J. Muse lowered his price target on Micron (MU) to $80 after its Q4 results, saying that while the softening demand from hyperscale customers was a known headwind, the "negative implications" of tariffs and Intel (INTC) CPU shortages were a new development. The analyst also cites "very little commentary" from the company related to the expected duration of the cloud inventory adjustment. Muse expects softness in the DRAM prices to possibly persist through Q2 of FY19 when the slowdown in pricing will decelerate. The analyst also keeps his Outperform rating on Micron longer term, saying its 4.4-times forward earnings multiple is "too cheap to ignore".
09/21/18
MSCO
09/21/18
NO CHANGE
Target $48
MSCO
Equal Weight
Micron headwinds apparent in guidance, says Morgan Stanley
Morgan Stanley analyst Joseph Moore said he was surprised at the magnitude of the upside Micron (MU) reported in the August quarter, but the fact that it guided revenues to be down in the strongest seasonal quarter validates some of his recent concerns. While demand factors such as Intel (INTC) microprocessor shortages and a few limited inventory adjustments that the company cited seem "narrow and temporary," the industry "almost certainly will" build inventory in the strongest seasonal quarter, which will have the effect of adding to supply for the seasonally weaker period in early 2019, contends Moore. While there remains debate about what cyclical concerns are already priced into the stock, "this is how memory downturns begin," concludes the analyst in in his note to investors. Moore keeps an Equal Weight rating on Micron shares and lowered his price target to $48 from $65.
09/21/18
RBCM
09/21/18
NO CHANGE
Target $69
RBCM
Outperform
Micron Q1 guidance conservative and memory cycle not done, says RBC Capital
RBC Capital analyst Amit Daryanani nudged his price target on Micron (MU) lower to $69 from $70 after its better than expected Q4 results and below-consensus Q1 guidance. The analyst believes that the company's outlook will prove to be "conservative" and keeps his Outperform rating, saying the headwinds of tariffs, Intel (INTC) CPU shortage, and inventory adjustment should prove temporary. Daryanani further points to Micron's higher expected FY19 capex guidance, adding that he sees the company "positively biased on DRAM supply" and its NAND headwinds impacting only a small part of its overall sales.
IBM IBM
$151.29

0.12 (0.08%)

07/30/18
WELS
07/30/18
INITIATION
Target $155
WELS
Market Perform
IBM resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Ed Caso resumed coverage of IBM with a Market Perform rating and $155 price target. While the company's overall revenue growth is "approaching positive territory again," the breadth and strength of the growth remains a "work-in-process and pretax margin has yet to show much improvement," Caso tells investors in a research note. The analyst sees limited share upside potential, but believes "downside risk protection seems solid." The "share bias is now up," Caso contends.
07/27/18
MSCO
07/27/18
NO CHANGE
Target $185
MSCO
Overweight
IBM momentum in Strategic Imperatives continuing, says Morgan Stanley
Morgan Stanley analyst Katy Huberty noted that investors often associate incumbency with risk, but she believes IBM's (IBM) penetration of 70% of the world's business data as a competitive advantage as she sees signs to suggest its momentum in signing Strategic Imperative deals is continuing. Strategic Imperative growth accelerated 3 points year-over-year in Q2, while estimated Core declines have been relatively stable, noted Huberty. Further supporting her view is the fact that the firm's Q2 CIO survey suggested that IBM ranks ahead of traditional consulting vendors like Accenture (ACN) on digital transformation, Huberty said. She maintains an Overweight rating and $185 price target on IBM shares.
07/30/18
RILY
07/30/18
NO CHANGE
Target $6.3
RILY
Buy
Groupon has ample liquidity to cover IBM award, says B. Riley FBR
B. Riley FBR analyst Sameet Sinha says Groupon (GRPN) has ample liquidity to cover the $83.5M patent award to IBM (IBM). The company has $93M in net cash and an untapped $250M revolver, Sinha tells investors in a research note. He keeps a Buy rating on Groupon shares with a $6.30 price target.
07/19/18
BMOC
07/19/18
NO CHANGE
Target $172
BMOC
IBM Q2 Cognitive segment results 'disappointing', says BMO Capital
BMO Capital analyst Keith Bachman lowered his price target on IBM to $172 from $175 and kept his Market Perform rating after its Q2 results. The analyst notes that while the company saw some progress on the services side and the Systems performance was better than expected, the Cognitive segment results were disappointing, particularly given that the business contains high-growth Watson and blockchain offerings. Bachman adds that the latest update on Cognitive segment is raising questions on whether IBM can sustain meaningful growth in operating income and free cash flows.
MSFT Microsoft
$114.70

1.13 (0.99%)

09/18/18
OPCO
09/18/18
NO CHANGE
Target $127
OPCO
Outperform
Microsoft price target raised to $127 from $120 at Oppenheimer
Oppenheimer analyst Tim Horan reiterated an Outperform rating on Microsoft and raised his price target to $127 ahead of Ignite 2018, the company's upcoming annual developer conference. In a research note to investors, Horan says he expects hybrid cloud will be the focus, highlighting improved capabilities/integration of 365, Azure, Dynamics and Teams/Skype. Separately, the analyst says channel checks suggest continued strong cloud demand.
09/17/18
ARGS
09/17/18
NO CHANGE
Target $320
ARGS
Buy
Adobe price target raised to $320 from $289 at Argus
Argus analyst Joseph Bonner raised his price target on Adobe to $320 from $289 and kept his Buy rating after its Q3 earnings beat, also raising his FY18 EPS view to $6.80 from $6.66 and FY19 to $7.73 from $7.22. The analyst is positive on the company's positioning "at the center of the exploding market for digital video content and advertising creation and management" with its "unique" software assets. Bonner adds that Adobe is accelerating its organic product refreshes and new rollouts while also partnering with industry leaders like Microsoft (MSFT), Accenture (ACN), Publicis, and Samsung (SSNLF) to drive continued growth. The analyst further notes the management's pattern of providing "underpromised and overdelivered" results.
09/18/18
WBLR
09/18/18
NO CHANGE
WBLR
Outperform
Fears of Google competition for Nutanix look overblown, says William Blair
Shares of Nutanix (NTNX) fell yesterday after The Information reported that Google (GOOG, GOOGL) is working on a potential hyperconverged infrastructure product that could conceptually compete with Nutanix, William Blair analyst Jason Ader tells investors in a research note titled "Fears of Google Entering HCI Space Look Overblown to Us". This is likely Google's response to what Microsoft (MSFT) has built with Azure Stack, which is Microsoft's HCI product that connects directly into its Azure public cloud service, Ader contends. He believes that if Google turn this into an actual packaged HCI product sold to a broad range of customers, it could create longer-term risk for Nutanix. However, thinks investors should consider that this appears to be another validation of the staying power of the on-premises market, which he says bodes well for Nutanix. Further, he points out that if Google were to decide to enter the HCI market more broadly, it would have a long way to go to establish itself in the enterprise against entrenched players like Nutanix and VMware (VMW). Google has not had great success selling into the enterprise historically and has little experience selling enterprise infrastructure appliances, Ader writes. The analyst reiterates an Outperform rating on Nutanix.
09/21/18
JMPS
09/21/18
NO CHANGE
JMPS
Market Perform
Big winner in Adobe deal for Marketo is Vista Equity, says JMP Securities
JMP Securities analyst Patrick Walravens believes the big winner in Adobe's (ADBE) agreement to acquire Marketo is Vista Equity Partners, which bought the B2B marketing cloud company in 2016 for $1.8B, suggesting nearly a 7x return on the equity investment in 2.5 years. He also suspects that Microsoft (MSFT), SAP (SAP) and Google (GOOGL) looked at Marketo, which may have driven the premium valuation that Walravens says Adobe agreed to pay. He maintains a Market Perform rating on Adobe shares following the deal announcement and leaves his estimates unchanged.
ORCL Oracle
$51.08

0.65 (1.29%)

09/18/18
WEDB
09/18/18
NO CHANGE
Target $49
WEDB
Neutral
'Not much in the way' of positive catalysts at Oracle, says Wedbush
Wedbush analyst Steve Koenig maintained a Neutral rating and $49 price target on Oracle following the company's Q1 results, telling investors in a research note that Q1 software revenue growth of 3% "probably won't impress investors." His checks suggest that NetSuite and Financials Cloud are doing best among Oracle's cloud portfolio, but that overall cloud renewal rates remain well below industry norms and says the company's key challenge will be to figure out how to capitalize on and monetize on customers' shift to the cloud with Oracle's database offering. He also lacks confidence that the company can make significant IaaS inroads into its database customer base or stem the rising tide of AWS (AMZN) in Oracle's enterprise market and doesn't see much in the way of positive catalysts.
09/21/18
KEYB
09/21/18
NO CHANGE
Target $286
KEYB
Overweight
Adobe's acquisition for Marketo could be 'quite synergistic,' says KeyBanc
After Adobe (ADBE) announced plans to acquire Marketo for $4.8B, KeyBanc analyst Brent Bracelin says a deal could be "quite synergistic," and and views it as a critical growth engine for Adobe that, when combined with Magento, helps round out the Experience Cloud portfolio. Bracelin expects the deal could could expand Adobe's marketing segment run-rate to nearly $3B next year while increasing the competitive overlap with the marketing and commerce segments of Salesforce (CRM) and Oracle (ORCL). Bracelin has an Overweight rating and $286 price target on Adobe shares.
09/18/18
OPCO
09/18/18
NO CHANGE
OPCO
Perform
Oracle's business 'off to a slow start' in Q1, says Oppenheimer
Oppenheimer analyst Brian Schwartz maintained a Perform rating on Oracle following the company's "soft" Q1 results and below consensus Q2 guidance. In a research note to investors, Schwartz says Oracle's business "got off to a slow start" in Q1, and cautions investors getting involved in "bottom fishing" Oracle shares in the hopes of outsized returns. He says Oracle's cloud transition has come "too late," resulting in steady customer and workload attrition to competitors, and says that the business remains under pressure and guidance suggests large company M&A and the corresponding risks "are near."
09/18/18
RBCM
09/18/18
NO CHANGE
Target $53
RBCM
Sector Perform
Oracle price target raised to $53 at RBC Capital after Q1 earnings
RBC Capital analyst Ross MacMillan nudged his price target on Oracle to $53 from $52 after its "broadly in-line" Q1 results, saying the earnings upside was driven by the lower tax rates and buybacks even though the outlook for Q2 was below expectations. MacMillan keeps his Sector Perform rating on the shares, stating that he sees no "meaningful case for multiple expansion" based on his expectations of declining growth rates and shrinking gross margins. The analyst further notes that Oracle's transition to a "cloud-centric world" has been "uneven" with a shrinking on-premise license business, adding that at current prices, risk-reward on the shares is "balanced".
BRK.A Berkshire Hathaway
$331,710.00

-1090 (-0.33%)

08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.
07/18/18
MSCO
07/18/18
NO CHANGE
MSCO
Equal Weight
Berkshire amendment signals interest in buying back shares, says Morgan Stanley
After Berkshire Hathaway's board authorized an amendment to the company's share repurchase program, Morgan Stanley analyst Kai Pan noted that Warren Buffett has indicated that the gap between Berkshire's intrinsic value and book value is widening and Pan thinks the amendment signals the company's interest in buying back its own shares. However, Berkshire will not initiate any buybacks until it releases Q2 earnings after market close on Friday, August 3, the analyst notes. Pan, who thinks "solid" Q2 results and buybacks should be positive catalysts, keeps an Equal Weight rating on Berkshire shares.
09/19/18
GDHS
09/19/18
NO CHANGE
GDHS
AutoNation doesn't profile as very good sale candidate, says Gordon Haskett
Gordon Haskett's Event-Driven researcher Don Bilson noted that Berkshire Hathaway's (BRK.A) Warren Buffett previously stated with his purchase of Van Tuyl Group that "this is the beginning of a journey that will have no end." While Berkshire buying AutoNation (AN) would "certainly obviate the need for [Chairman and CEO Mike] Jackson to continue on with his search" for a successor, Bilson said AutoNation "doesn't profile as a very good sale candidate" and "this doesn't set up as a situation where Jackson might sell the company as part of his exit."
08/08/18
MSCO
08/08/18
NO CHANGE
Target $67
MSCO
Overweight
Southwest would be good strategic fit for Berkshire, says Morgan Stanley
Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan, who said he has no knowledge of any M&A discussions and noted that the airlines have not commented. Given that background, he analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation, in which he also thinks Berkshire would divest its current holdings in American Airlines (AAL), Delta (DAL) and United Continental (UAL). Pan has an Overweight rating and $67 price target on Southwest shares.
BRK.B Berkshire Hathaway
$220.57

-1.24 (-0.56%)

05/07/18
LEHM
05/07/18
NO CHANGE
Target $367500
LEHM
Overweight
Berkshire price target raised to $367,500 from $357,000 at Barclays
Barclays analyst Jay Gelb raised his price target for Berkshire Hathaway Class A (BRK.A) to $367,500 from $357,000 and for Class B (BRK.B) to $245 from $238. Berkshire is well positioned to benefit from an expanding economy, higher short-term interest rates, and potential future accretive acquisitions, Gelb tells investors following the company's Q1 results. He keeps an Overweight rating on the shares.
06/21/18
BERN
06/21/18
NO CHANGE
BERN
Amazon/JPMorgan/Berkshire venture still negative for drug supply chain, says Bernstein
Bernstein analyst Lance Wilkes notes that Amazon (AMZN), Berkshire Hathaway (BRK.A; BRK.B) and JPMorgan (JPM) announced the appointment of Atul Gawande as the CEO of their new healthcare joint venture, effective July 9th. The analyst sees this appointment as indicating an emphasis on enablement of change in the system, along with thought and policy leadership, and believes the appointment of an operating oriented President or COO could refine the outlook for scope. Wilkes continues to see this venture as negative for drug supply chain and self-insured employer oriented MCOs.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$273.44

-1.58 (-0.57%)

, SPX

S&P 500

$0.00

(0.00%)

21:11
10/23/18
10/23
21:11
10/23/18
21:11
Periodicals
Trump escalates attacks on FOMC head Powell, WSJ reports »

In an interview with The…

SPY

SPDR S&P 500 ETF Trust

$273.44

-1.58 (-0.57%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$36.41

0.17 (0.47%)

21:06
10/23/18
10/23
21:06
10/23/18
21:06
Initiation
Conagra Brands initiated at Goldman Sachs »

Conagra Brands resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

YUM

Yum! Brands

$88.81

-0.52 (-0.58%)

20:41
10/23/18
10/23
20:41
10/23/18
20:41
Downgrade
Yum! Brands rating change at Stifel »

Yum! Brands downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

WING

Wingstop

$69.62

-0.48 (-0.68%)

20:38
10/23/18
10/23
20:38
10/23/18
20:38
Downgrade
Wingstop rating change at Stifel »

Wingstop downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BJRI

BJ's Restaurants

$65.49

-1.4 (-2.09%)

20:35
10/23/18
10/23
20:35
10/23/18
20:35
Downgrade
BJ's Restaurants rating change at Stifel »

BJ's Restaurants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 05

    Nov

  • 06

    Nov

AMSSY

AMS AG

$0.00

(0.00%)

20:34
10/23/18
10/23
20:34
10/23/18
20:34
Downgrade
AMS AG rating change at JPMorgan »

AMS AG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.60

0.185 (2.20%)

20:25
10/23/18
10/23
20:25
10/23/18
20:25
Hot Stocks
Ford names Anning Chen the new head of China business »

Earlier today, Ford…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

  • 13

    Dec

T

AT&T

$33.03

0.37 (1.13%)

, BA

Boeing

$349.74

-6.24 (-1.75%)

20:25
10/23/18
10/23
20:25
10/23/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

T

AT&T

$33.03

0.37 (1.13%)

BA

Boeing

$349.74

-6.24 (-1.75%)

UPS

UPS

$114.22

-1.38 (-1.19%)

TMO

Thermo Fisher

$223.46

-2.29 (-1.01%)

GD

General Dynamics

$187.80

-2.26 (-1.19%)

NOC

Northrop Grumman

$304.17

-2.6 (-0.85%)

BSX

Boston Scientific

$36.03

-0.6 (-1.64%)

NSC

Norfolk Southern

$156.94

-7 (-4.27%)

ITW

Illinois Tool Works

$126.51

-0.89 (-0.70%)

SIRI

Sirius XM

$5.96

-0.06 (-1.00%)

HLT

Hilton

$68.89

-1.28 (-1.82%)

FCX

Freeport McMoRan

$11.61

-0.395 (-3.29%)

QSR

Restaurant Brands

$56.80

0.15 (0.26%)

NDAQ

Nasdaq

$81.73

0.72 (0.89%)

IVZ

Invesco

$21.18

0.06 (0.28%)

OC

Owens Corning

$47.46

-1.26 (-2.59%)

NYCB

New York Community Bancorp

$9.41

0.03 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 30

    Oct

  • 06

    Nov

  • 06

    Nov

  • 12

    Nov

  • 13

    Dec

NDLS

Noodles & Company

$12.70

0.11 (0.87%)

20:12
10/23/18
10/23
20:12
10/23/18
20:12
Conference/Events
Noodles & Company participates in a conference call with Jefferies »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

LIQT

LiqTech

$1.31

-0.01 (-0.76%)

20:02
10/23/18
10/23
20:02
10/23/18
20:02
Conference/Events
LiqTech to host conference call »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

19:45
10/23/18
10/23
19:45
10/23/18
19:45
General news
Breaking General news story  »

Kansas City Federal…

FBMS

First Bancshares

$35.68

-0.53 (-1.46%)

19:36
10/23/18
10/23
19:36
10/23/18
19:36
Earnings
First Bancshares reports Q3 adjusted EPS 62c, consensus 60c »

Reports Q3 NII $21.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTI

Proteostasis

$7.39

0.22 (3.07%)

19:30
10/23/18
10/23
19:30
10/23/18
19:30
Syndicate
Proteostasis 11M share Secondary priced at $6.75 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

NCOM

National Commerce

$37.80

0.38 (1.02%)

19:19
10/23/18
10/23
19:19
10/23/18
19:19
Earnings
National Commerce reports Q3 EPS 59c, consensus 63c »

"We are pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Dec

ON

ON Semiconductor

$16.09

0.21 (1.32%)

19:14
10/23/18
10/23
19:14
10/23/18
19:14
Hot Stocks
ON Semiconductor announces CE certification for Sigfox RF solution »

ON Semiconductor has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 08

    May

LPT

Liberty Property

$41.51

1.285 (3.19%)

, CMCSA

Comcast

$35.63

-0.12 (-0.34%)

19:10
10/23/18
10/23
19:10
10/23/18
19:10
Recommendations
Liberty Property, Comcast analyst commentary at MUFG »

Liberty Property price…

LPT

Liberty Property

$41.51

1.285 (3.19%)

CMCSA

Comcast

$35.63

-0.12 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 07

    Nov

MANH

Manhattan Associates

$47.61

-0.36 (-0.75%)

, RRC

Range Resources

$16.46

-0.24 (-1.44%)

18:55
10/23/18
10/23
18:55
10/23/18
18:55
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

MANH

Manhattan Associates

$47.61

-0.36 (-0.75%)

RRC

Range Resources

$16.46

-0.24 (-1.44%)

TER

Teradyne

$32.20

-0.09 (-0.28%)

TSS

TSYS

$92.62

-0.85 (-0.91%)

NAVI

Navient

$12.40

-0.13 (-1.04%)

COF

Capital One

$87.12

-1.5 (-1.69%)

JNPR

Juniper

$27.37

-1.11 (-3.90%)

RHI

Robert Half

$64.01

0.63 (0.99%)

CMTA

Clementia Pharmaceuticals

$10.00

0.41 (4.28%)

APC

Anadarko

$61.84

-2.1 (-3.28%)

COG

Cabot Oil & Gas

$22.72

-0.44 (-1.90%)

AKRX

Akorn

$6.47

-0.12 (-1.82%)

IIVI

II-VI

$38.01

-0.44 (-1.14%)

NDLS

Noodles & Company

$12.70

0.11 (0.87%)

MKSI

MKS Instruments

$73.35

-1.13 (-1.52%)

IRBT

iRobot

$91.69

0.91 (1.00%)

CSL

Carlisle

$102.37

-0.64 (-0.62%)

TXN

Texas Instruments

$100.25

0.51 (0.51%)

EW

Edwards Lifesciences

$148.31

-1.175 (-0.79%)

AI

Arlington Asset Investment

$8.34

-0.07 (-0.83%)

UMBF

UMB Financial

$62.37

-1.32 (-2.07%)

FCF

First Commonwealth

$14.66

0.245 (1.70%)

VAR

Varian Medical

$104.27

-0.24 (-0.23%)

QEP

QEP Resources

$9.74

-0.52 (-5.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 26

    Oct

  • 31

    Oct

  • 01

    Nov

  • 09

    Nov

  • 25

    Oct

BLK

BlackRock

$387.58

-4.76 (-1.21%)

, ISNPY

Intesa Sanpaolo

$0.00

(0.00%)

18:51
10/23/18
10/23
18:51
10/23/18
18:51
Periodicals
BlackRock cools on buying Intesa asset management unit stake, Bloomberg says »

BlackRock's (BLK)…

BLK

BlackRock

$387.58

-4.76 (-1.21%)

ISNPY

Intesa Sanpaolo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

PAAS

Pan American Silver

$15.09

-0.19 (-1.24%)

18:50
10/23/18
10/23
18:50
10/23/18
18:50
Hot Stocks
Pan American Silver announces major discovery at La Colorada in Mexico »

Pan American Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

PFE

Pfizer

$44.09

-0.28 (-0.63%)

, LLY

Eli Lilly

$110.41

-1.66 (-1.48%)

18:42
10/23/18
10/23
18:42
10/23/18
18:42
Hot Stocks
Pfizer, Eli Lilly: Phase 3 study of tanezumab met all three co-primary endpoints »

Pfizer (PFE) and Eli…

PFE

Pfizer

$44.09

-0.28 (-0.63%)

LLY

Eli Lilly

$110.41

-1.66 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

EXPI

eXp World Holdings

$12.11

-0.39 (-3.12%)

18:31
10/23/18
10/23
18:31
10/23/18
18:31
Hot Stocks
eXp World Holdings signs LOI to acquire VirBELA, terms not disclosed »

eXp World Holdings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

IIVI

II-VI

$38.01

-0.44 (-1.14%)

18:26
10/23/18
10/23
18:26
10/23/18
18:26
Initiation
II-VI initiated at DA Davidson »

II-VI initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

XOM

Exxon Mobil

$79.83

-1.32 (-1.63%)

, CVX

Chevron

$113.41

-3.82 (-3.26%)

18:22
10/23/18
10/23
18:22
10/23/18
18:22
Periodicals
Endeavor Energy explores possible sale of company, WSJ reports »

Endeavor Energy Resources…

XOM

Exxon Mobil

$79.83

-1.32 (-1.63%)

CVX

Chevron

$113.41

-3.82 (-3.26%)

BP

BP

$42.30

-0.855 (-1.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

VMI

Valmont

$127.55

-1.68 (-1.30%)

18:09
10/23/18
10/23
18:09
10/23/18
18:09
Hot Stocks
Breaking Hot Stocks news story on Valmont »

Valmont lowers FY18 free…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

VMI

Valmont

$127.55

-1.68 (-1.30%)

18:08
10/23/18
10/23
18:08
10/23/18
18:08
Earnings
Valmont lowers FY18 EPS view to $7.50-$7.65 from $7.55-$7.65, consensus $7.58 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.